ES2115600T3 - Derivados de 1-metilcarbapenem y procedimiento para su preparacion. - Google Patents

Derivados de 1-metilcarbapenem y procedimiento para su preparacion.

Info

Publication number
ES2115600T3
ES2115600T3 ES91115083T ES91115083T ES2115600T3 ES 2115600 T3 ES2115600 T3 ES 2115600T3 ES 91115083 T ES91115083 T ES 91115083T ES 91115083 T ES91115083 T ES 91115083T ES 2115600 T3 ES2115600 T3 ES 2115600T3
Authority
ES
Spain
Prior art keywords
derivatives
procedure
preparation
methyl carbapenem
carbapenem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91115083T
Other languages
English (en)
Inventor
Tameo Iwasaki
Kazuhiko Kondo
Hiroshi Horikawa
Totaro Yamaguchi
Tadahiro Matsushita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2115600T3 publication Critical patent/ES2115600T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

DERIVADOS DE 1-METILCARBAPENEM DE LA FORMULA: DONDE R ELEVADO 1 ES UN ATOMO DE HIDROGENO O UN GRUPO DE PROTECCION HIDROXI, R (AL CUADRADO) EN UN ATOMO DE HIDROGENO O UN RESIDUO DE ESTER, R ELEVADO 3 ES UN ATOMO DE HIDROGENO O UN GRUPO ALCALINO BAJO, O SALES DEL MISMO, PROVISTO DE ACTIVIDADES ANTIMICROBIANAS EXCELENTES Y SON UTILES COMO DROGA ANTIMICROBIANA.
ES91115083T 1990-09-07 1991-09-06 Derivados de 1-metilcarbapenem y procedimiento para su preparacion. Expired - Lifetime ES2115600T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23842090 1990-09-07
JP7028591 1991-01-14

Publications (1)

Publication Number Publication Date
ES2115600T3 true ES2115600T3 (es) 1998-07-01

Family

ID=26411452

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91115083T Expired - Lifetime ES2115600T3 (es) 1990-09-07 1991-09-06 Derivados de 1-metilcarbapenem y procedimiento para su preparacion.

Country Status (16)

Country Link
US (1) US5153187A (es)
EP (1) EP0474243B1 (es)
JP (1) JPH0745500B2 (es)
KR (1) KR0148379B1 (es)
CN (1) CN1033455C (es)
AT (1) ATE164582T1 (es)
AU (1) AU630574B2 (es)
CA (1) CA2050255C (es)
DE (1) DE69129175T2 (es)
DK (1) DK0474243T3 (es)
ES (1) ES2115600T3 (es)
FI (2) FI95470C (es)
HU (2) HU211122B (es)
IE (1) IE913065A1 (es)
IL (1) IL99399A0 (es)
SG (1) SG49607A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
JP2569455B2 (ja) * 1992-03-06 1997-01-08 田辺製薬株式会社 β−ラクタム誘導体の製法
EP0937725A3 (en) 1992-04-28 2004-12-01 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for hydroxy group
US5587474A (en) * 1992-06-18 1996-12-24 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for carboxyl group
US5442055A (en) * 1992-11-13 1995-08-15 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5631363A (en) * 1992-11-13 1997-05-20 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5495012A (en) * 1992-12-28 1996-02-27 Tanabe Seiyaku Co., Ltd. Process for preparing optically active 4-mercapto-2-pyrrolidone derivative and intermediate therefor
JP2701685B2 (ja) * 1992-12-28 1998-01-21 田辺製薬株式会社 光学活性４−メルカプト−２−ピロリドン誘導体及びその合成中間体の製法
EP0704446A4 (en) * 1993-06-16 1996-06-12 Sumitomo Pharma NEW BETA LACTAM COMPOUND AND A METHOD FOR THEIR PRODUCTION
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
WO1996007655A1 (en) * 1994-09-06 1996-03-14 Banyu Pharmaceutical Co., Ltd. Novel carbapenem derivative
JP2969616B2 (ja) 1994-11-24 1999-11-02 田辺製薬株式会社 ４−メルカプトピロリジン化合物の製法
WO1997041853A1 (en) 1996-05-09 1997-11-13 Sankyo Company, Limited Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
JPH1077285A (ja) 1996-09-04 1998-03-24 Sumitomo Pharmaceut Co Ltd 新規なβ−ラクタム化合物およびその製造法
KR100377448B1 (ko) 2000-08-10 2003-03-26 동화약품공업주식회사 카바페넴 항생물질의 중간체 및 그의 제조방법
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
JP4377231B2 (ja) 2001-11-05 2009-12-02 大日本住友製薬株式会社 新規なカルバペネム化合物
WO2004089954A1 (ja) 2003-04-08 2004-10-21 Sumitomo Pharmaceuticals Co., Ltd. 新規なカルバペネム化合物
CA2577924A1 (en) * 2004-09-03 2006-03-09 Dainippon Sumitomo Pharma Co., Ltd. Novel carbapenem compound
JPWO2006103999A1 (ja) * 2005-03-25 2008-09-04 大日本住友製薬株式会社 新規なカルバペネム化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
DE68919508T2 (de) * 1988-04-01 1995-07-20 Sankyo Co 2-(Heterocyclylthio)carbapenemderivate, deren Herstellung und deren Verwendung als Antibiotika.

Also Published As

Publication number Publication date
DE69129175D1 (de) 1998-05-07
DK0474243T3 (da) 1998-12-07
EP0474243A1 (en) 1992-03-11
KR920006358A (ko) 1992-04-27
SG49607A1 (en) 1998-06-15
CA2050255A1 (en) 1992-03-08
CN1033455C (zh) 1996-12-04
FI914187L (fi) 1992-03-08
FI95470B (fi) 1995-10-31
EP0474243B1 (en) 1998-04-01
CA2050255C (en) 1997-02-04
FI100399B (fi) 1997-11-28
AU8347991A (en) 1992-03-12
FI952101L (fi) 1995-05-03
KR0148379B1 (ko) 1998-11-02
JPH0745500B2 (ja) 1995-05-17
CN1060093A (zh) 1992-04-08
HUT59410A (en) 1992-05-28
FI952101A0 (fi) 1995-05-03
HU211122B (en) 1995-10-30
FI914187A0 (fi) 1991-09-05
AU630574B2 (en) 1992-10-29
US5153187A (en) 1992-10-06
HU211892A9 (en) 1995-12-28
ATE164582T1 (de) 1998-04-15
FI95470C (fi) 1996-02-12
IL99399A0 (en) 1992-08-18
IE913065A1 (en) 1992-03-11
JPH04279588A (ja) 1992-10-05
DE69129175T2 (de) 1998-09-03
HU912884D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
ECSP941096A (es) Procedimiento para la preparacion de un derivado indol
CZ178594A3 (en) Carbamates and agents for plant protection containing thereof
GR861625B (en) Optically active pyridobenzoxazines derivatives and intermediate compounds thereof
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
MX9700885A (es) Nuevas heteroariloxazolidinonas.
ES2061581T3 (es) Un procedimiento para preparar un compuesto cefem.
ES468119A1 (es) Un procedimiento para la preparacion de triazinas
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT59410A (en) Process for producing 1-methyl carbapenem derivatives and pharmaceutical compositions comprising same as active ingredient
EP0536402A4 (en) Piperidine derivative
BG50163A3 (en) Method for preparing of acyl derivatives
YU83993A (sh) Novi derivati piridon organske kiseline
AR027578A1 (es) Derivados de indano
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
JO1629B1 (en) Andadnodol compounds i
ES2118094T3 (es) Derivados del acido carbamico y procedimiento para su preparacion.
DE3570249D1 (en) Enzyme-inhibitory griseolic acid derivatives, and their use
DE69007356D1 (de) Zyklisches Tetrapeptid und Verfahren zu dessen Herstellung.
ES2077042T3 (es) Derivados de benzoxazina, derivados de benzotiazina y herbicidas que comprenden los mismos.
ES2037758T3 (es) Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion.
ES2101738T3 (es) Tintes de benzoxacina.
ES2058192T3 (es) Diesteres de acido fosforico y sus sales.
ES2001006A4 (es) Compuestos sustituidos de 2,6-piridina sustituida

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 474243

Country of ref document: ES